Today at #ASCO26, Betul Gok Yavuz, MD, PhD is presenting during the poster session. Stop by to learn more about how somatic copy-number alterations may help identify biomarkers for risk stratification and clinical decision-making in #RCC brain metastases. @UChicagoUrology
#FellowshipRetreat is a time to relax, reconnect, and network as we learn about job search, transitioning into faculty, collaboration, mentorship, and the future of our field.
Thank you to our invited panelists and @UChicagoHemOnc Alumni.
Funded two-year research position is available, focusing on cancer cell therapy in lymphoma and multiple myeloma. This position is open to candidates who do not require visa sponsorship. Please feel free to DM with any questions! @Inside_TheMatch
Many leaders in medicine are focused on AI and how it’s going to solve problems in medicine. Maybe.
But doctors with great clinical acumen, empathy, and the wisdom to make the right judgment call are the ones we need more of, and who patients want and seek out. This is the important stuff.
Excited to present another poster at #ACC26 on prior myocardial injury and clinical outcomes in ICI-associated myocarditis! Grateful for the support of my amazing mentor @HanZhuMD, thank you to @Ron_Witteles for stopping by, and always proud to represent @StanfordMedRes
I 💯 agree. Cancer diagnosis by itself should not be a strict contra indication to ECMO or other MCS. Cardio-oncology/oncology input in these patients is vital!
At #ASH25, Ben Derman, MD, (@bdermanmd) emphasizes that pts with sustained deep MRD negativity and no high-risk features may safely discontinue maintenance therapy, as MRD-guided monitoring helps personalize treatment in multiple myeloma. @UChicagoHemOnc
'Super excited to welcome and congratulate our incoming fellowship class. We can't wait to have you join the program next summer! #fellowshipmatch2025@TheNRMP
HISTORIC AND PARADIGM CHANGING:
FDA approves daratumumab for high risk smoldering multiple myeloma based on the AQUILA trial— the FIRST ever treatment approved for this indication.
Excellent news and thanks to @JNJInnovMed and the huge worldwide team of investigators for making it happen. @thanosdimop@SagarLonialMD@PlasmaCellPete